Results: Compared with AR-ER -, the AR+ER - immunophenotype was accounted for a high proportion in grade I and II (9.0 and 32.4%), the negative lymph node BCs (74.8%), good and moderate NPI (23.4 and 57.7%), the non - vascular invasion breast cancers (63.1%), as well (p < 0.05 or 0.001).